Contact Information: CONTACT: Michael Brennan, Chairman Email: Telephone: (805) 557-0614
MIT 1000 System Receives Excellent Independent Evaluation Results
| Source: Micro Imaging Technology, Inc.
SAN CLEMENTE, CA--(Marketwire - August 4, 2008) - Micro Imaging Technology, Inc. (OTCBB : MMTC ) announces that its product, the MIT 1000 Rapid Microbial
Identification System, has received additional test results from two
independent evaluators. Recently, the Company announced that the USDA's
chief scientific center, Agricultural Research Service, and Pacific Coast
Analytical Services (PCAS), a full service testing laboratory, are
evaluating the MIT 1000 system for the detection and identification of the
most widespread food pathogens; including Listeria, E.coli, and Salmonella.
The MIT 1000 is being compared with conventional testing processes and
evaluated for identification accuracy, speed, and test costs. The
evaluation protocol required that the MIT System be tasked with correctly
identifying the Listeria bacteria and correctly identifying other organisms
as not Listeria. The latter is to test the System's vulnerability for
false positive results.
The combined results after 115 Listeria confirmation tests and 153 false
positive tests conducted were: The MIT 1000 recorded a perfect 100% score
for the confirmation tests and had only 13 false positive that were all
attributed to the misidentification of only one bacterial species,
Aeromonas hydrophila as Listeria.
"We are delighted with the results received by both organizations. While
the false positive results were higher than we would like, they are
competitive with other bacteria identification systems. Also, given that
the false positives were isolated to one specie only, adding it to our
database will eliminate future false positives for that species," stated
Michael Brennan, MIT's Chairman. "The continued feedback by our evaluators
enables us to make further improvements to the System which was one of the
main objectives of these evaluations," stated John Ricardi, MIT's VP of
Business Development.
About Micro Imaging Technology
The Company has developed and patented a technology for rapid microbe
detection and identification. This System measures scattered light
intensity as individual microbes pass through a laser beam. The intensity
pattern of the scattered light is a direct consequence of the size, shape
and external and internal optical characteristics of the microbe. The MIT
System is totally GREEN, is non-biological, and does not rely on biological
agents, conventional chemical processing, fluorescent tags, gas
chromatography or DNA analysis -- uses only clean water as a test medium.
MIT has demonstrated the ability to detect and identify, within several
minutes, the microbes Escherichia coli, Listeria, Salmonella,
Staphylococcus aureus, and other pathogenic bacteria. MIT recently
performed over 300 tests for the identification of the aforementioned
contaminants and scored 95% accuracy. The System can currently identify 23
species of bacteria and is easily expandable. The identification process
has been verified by North American Science Associates, Inc. (NAMSA), an
independent, internationally recognized biological testing laboratory. The
NAMSA Test Report compiled from their own tests, in the Company's opinion,
demonstrated the accuracy, speed and efficiency of the MIT System over
conventional processes and is available from the Company. The Company is in
the process of completing another independently designed evaluation test;
conducted by the Association of Analytic Communities (AOAC).
This release contains statements that are forward-looking in nature.
Statements that are predictive in nature, that depend upon or refer to
future events or conditions or that include words such as "expects,"
"anticipates," "intends," "plans," "believes," "estimates," and similar
expressions are forward-looking statements. These statements are made based
upon information available to the Company as of the date of this release,
and we assume no obligation to update any such forward-looking statements.
These statements are not guarantees of future performance and actual
results could differ materially from our current expectations. Factors
that could cause or contribute to such differences include, but are not
limited to dependence on suppliers; short product life cycles and
reductions in unit selling prices; delays in development or shipment of new
products; lack of market acceptance of our new products or services;
inability to continue to develop competitive new products and services on a
timely basis; introduction of new products or services by major
competitors; our ability to attract and retain qualified employees;
inability to expand our operations to support increased growth; and
declining economic conditions, including a recession. These and other
factors and risks associated with our business are discussed from time to
time within our filings with the Securities and Exchange Commission.